v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
IPO
Convertible Preferred Stock
Common Stock
Common Stock
IPO
Additional Paid-In Capital
Additional Paid-In Capital
IPO
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Temporary equity beginning balance at Dec. 31, 2024     $ 126,756            
Temporary equity beginning balance, shares at Dec. 31, 2024     96,941,453            
Beginning balance at Dec. 31, 2024 $ (54,643)         $ 3,684     $ (58,327)
Outstanding Beginning balance, shares at Dec. 31, 2024       4,066,969          
Issuance of common stock in initial public offering, net of discounts and issuance costs of $10.4 million   $ 87,495         $ 87,495    
Issuance of common stock in initial public offering, net of discounts and issuance costs of $10.4 million, shares         6,120,661        
Temporary Equity conversion of convertible preferred stock into common stock upon initial public offering     $ (126,756)            
Temporary Equity conversion of convertible preferred stock into common stock upon initial public offering, shares     (96,941,453)            
Conversion of convertible preferred stock into common stock upon initial public offering 126,756         126,756      
Conversion of convertible preferred stock into common stock upon initial public offering, shares       11,439,838          
Exercise of common stock options 105         105      
Exercise of common stock options, shares       58,058          
Vesting of restricted common stock 25         25      
Vesting of restricted common stock, shares       7,490          
Stock-based compensation expense 867         867      
Unrealized loss on short-term investments (3)             $ (3)  
Net loss (23,677)               (23,677)
Ending balance at Jun. 30, 2025 136,925         218,932   (3) (82,004)
Outstanding Ending balance, shares at Jun. 30, 2025       21,693,016          
Beginning balance at Mar. 31, 2025 150,689         218,282   44 (67,637)
Outstanding Beginning balance, shares at Mar. 31, 2025       21,688,172          
Exercise of common stock options 4         4      
Exercise of common stock options, shares       973          
Vesting of restricted common stock 12         12      
Vesting of restricted common stock, shares       3,871          
Stock-based compensation expense 634         634      
Unrealized loss on short-term investments (47)             (47)  
Net loss (14,367)               (14,367)
Ending balance at Jun. 30, 2025 136,925         218,932   (3) (82,004)
Outstanding Ending balance, shares at Jun. 30, 2025       21,693,016          
Beginning balance at Dec. 31, 2025 106,633         222,470   81 (115,918)
Outstanding Beginning balance, shares at Dec. 31, 2025       21,815,353          
Exercise of common stock options 7         7      
Exercise of common stock options, shares       1,720          
Issuance of common stock under employee stock purchase plan 259         259      
Issuance of common stock under employee stock purchase plan , Shares       67,085          
Stock-based compensation expense 3,954         3,954      
Unrealized loss on short-term investments (81)             (81)  
Net loss (35,975)               (35,975)
Ending balance at Jun. 30, 2026 74,797         226,690     (151,893)
Outstanding Ending balance, shares at Jun. 30, 2026       21,884,158          
Beginning balance at Mar. 31, 2026 86,986         224,478   14 (137,506)
Outstanding Beginning balance, shares at Mar. 31, 2026       21,816,385          
Exercise of common stock options 3         3      
Exercise of common stock options, shares       688          
Issuance of common stock under employee stock purchase plan 259         259      
Issuance of common stock under employee stock purchase plan , Shares       67,085          
Stock-based compensation expense 1,950         1,950      
Unrealized loss on short-term investments (14)             $ (14)  
Net loss (14,387)               (14,387)
Ending balance at Jun. 30, 2026 $ 74,797         $ 226,690     $ (151,893)
Outstanding Ending balance, shares at Jun. 30, 2026       21,884,158